ストックスクリーナーアプリを入手
1.74
9.43%
0.15
前日終値:
$1.59
開ける：
$1.6
24時間の取引高:
2.40M
Relative Volume:
3.43
時価総額：
$64.44M
収益：
-
当期純損益:
$-25.94M
株価収益率:
-1.2609
EPS:
-1.38
ネットキャッシュフロー:
$-15.79M
1週間 パフォーマンス:
+6.75%
1か月 パフォーマンス:
+41.46%
6か月 パフォーマンス:
+1.75%
1年 パフォーマンス:
-13.86%
1日の値動き範囲:
$1.60
$1.89
1週間の範囲:
$1.49
$1.89
52週間の値動き範囲:
$0.87
$2.74
MAIA Biotechnology Inc Stock (MAIA) Company Profile
名前
MAIA Biotechnology Inc
セクター
電話
312 416 8592
住所
444 West Lake Street, Suite 1700, Chicago
MAIA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.74 | 58.88M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
MAIA Biotechnology Inc (MAIA) 最新ニュース
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 9.4% – Time to Buy? - Defense World
Trend Report: Should I buy BOSC stock nowJuly 2025 Highlights & AI Powered Trade Plan Recommendations - baoquankhu1.vn
MAIA Biotechnology (MAIA) Price Target Decreased by 15.37% to 10.48 - Nasdaq
MAIA Biotechnology Highlights Strategy in New Investor Presentation - TipRanks
Smith Stan buys MAIA Biotechnology shares worth $9,958 By Investing.com - Investing.com Australia
Smith Stan buys MAIA Biotechnology shares worth $9,958 - Investing.com
Will MAIA Biotechnology Inc. stock sustain dividend payoutsJuly 2025 Opening Moves & Risk Managed Investment Strategies - Улправда
Will MAIA Biotechnology Inc. stock deliver compounding returns2025 Fundamental Recap & AI Forecasted Entry and Exit Points - Улправда
Can MAIA Biotechnology Inc. stock deliver strong annual returnsWeekly Trade Recap & Expert Curated Trade Ideas - Улправда
MAIA Biotechnology (MAIA) director granted 24,060 options under 2021 plan - Stock Titan
MAIA Biotechnology (MAIA) director reports grant of 29,216 stock options - Stock Titan
MAIA Biotechnology (MAIA) director receives 25,206 stock options exercisable at $1.53 - Stock Titan
MAIA Biotechnology, Inc. (MAIA) reports 29,789 director stock options at $1.53 - Stock Titan
[Form 4] MAIA Biotechnology, Inc. Insider Trading Activity - Stock Titan
MAIA Biotechnology (NASDAQ: MAIA) reports 24,633 stock options grant - Stock Titan
A stock that deserves closer examination: MAIA Biotechnology Inc (MAIA) - uspostnews.com
MAIA Biotechnology, Inc. Common Stock (NYSE:MAIA) Stock Quote - FinancialContent
MAIA Biotechnology announces open market purchases by CEO, directors - MSN
MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Short Interest Up 144.9% in December - MarketBeat
MAIA Biotechnology (MAIA) Price Target Decreased by 13.32% to 12.38 - MSN
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings - The Manila Times
Louie Ngar Yee buys MAIA Biotechnology (MAIA) shares worth $99999 By Investing.com - Investing.com Canada
Stan Smith buys MAIA Biotechnology shares worth $69,999 By Investing.com - Investing.com Canada
Chaouki Steven M buys MAIA Biotechnology shares worth $49999 By Investing.com - Investing.com Australia
Stan Smith buys MAIA Biotechnology shares worth $69,999 - Investing.com
Louie Ngar Yee buys MAIA Biotechnology (MAIA) shares worth $99999 - Investing.com
MAIA Biotechnology Directors Increase Holdings - TradingView — Track All Markets
MAIA (MAIA) director boosts stake with 57,189-share buy and new options - Stock Titan
MAIA Biotechnology (MAIA) director reports stock purchase and new options - Stock Titan
MAIA Biotechnology (MAIA) director reports stock and option purchases - Stock Titan
MAIA Biotechnology, Inc. announced that it has received $1.289791 million in funding - marketscreener.com
Swing Trade: Why hedge funds are buying MAIA Biotechnology Inc stockJuly 2025 Movers & Safe Entry Momentum Stock Tips - moha.gov.vn
MAIA Biotechnology Earnings Notes - Trefis
Can MAIA Biotechnology Inc. stock double in next 5 yearsPortfolio Gains Report & Capital Efficiency Focused Ideas - DonanımHaber
How MAIA Biotechnology Inc. stock compares to industry benchmarksWeekly Profit Summary & AI Forecasted Entry/Exit Points - Улправда
Can MAIA Biotechnology Inc. stock maintain operating marginsJuly 2025 Intraday Action & Expert Approved Momentum Ideas - bolumsonucanavari.com
Why MAIA Biotechnology Inc. stock is upgraded to buy2025 Valuation Update & Daily Growth Stock Tips - DonanımHaber
Can MAIA Biotechnology Inc. stock deliver consistent earnings growth2025 Historical Comparison & Fast Exit/Entry Strategy Plans - Улправда
MAIA Biotechnology, Inc. (MAIA) Gets a Buy from Noble Financial - The Globe and Mail
MAIA Biotechnology announces $2.25M private placement deal - MSN
MAIA Biotechnology Announces $2.25M Private Placement Deal - TipRanks
MAIA Biotechnology (NYSE American: MAIA) details $2.25M private placement - Stock Titan
MAIA Biotechnology Announces $1.51 Million Private Placement - The Manila Times
MAIA Biotechnology, Inc. announced that it expects to receive $1.289791 million in funding - marketscreener.com
MAIA Biotechnology Announces Significant Insider Buying - TipRanks
MAIA Biotechnology, Inc. Announces Key Developments in Cancer Therapy - TradingView — Track All Markets
MAIA Biotechnology (NYSE: MAIA) starts Ateganosine Phase 3 trial and notes insider buying - Stock Titan
MAIA Biotechnology (NYSE American: MAIA) begins Phase 3 NSCLC study of telomere-targeting ateganosine - Stock Titan
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer - Yahoo Finance
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential - Yahoo Finance
MAIA Biotechnology (MAIA) doses first patient in THIO-104 Phase 3 NSCLC trial - Stock Titan
MAIA Biotechnology Inc (MAIA) 財務データ
収益
当期純利益
現金流量
EPS
MAIA Biotechnology Inc (MAIA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| CHAOUKI STEVEN M | Director |
Dec 22 '25 |
Buy |
1.22 |
40,849 |
49,999 |
151,873 |
| Louie Ngar Yee | Director |
Dec 22 '25 |
Buy |
1.22 |
81,699 |
100,000 |
1,248,888 |
| Smith Stan | Director |
Dec 05 '25 |
Buy |
1.20 |
13,740 |
16,441 |
4,580 |
| Vitoc Vlad | Chief Executive Officer |
Nov 28 '25 |
Buy |
1.14 |
50,000 |
56,830 |
881,421 |
| Vitoc Vlad | Chief Executive Officer |
Nov 26 '25 |
Buy |
1.05 |
22,000 |
23,019 |
853,421 |
| Luput Cristian | Director |
Nov 26 '25 |
Buy |
1.08 |
20,000 |
21,616 |
419,483 |
| Luput Cristian | Director |
Nov 28 '25 |
Buy |
1.11 |
18,145 |
20,230 |
437,628 |
| Smith Stan | Director |
Nov 26 '25 |
Buy |
1.04 |
15,000 |
15,582 |
1,364,289 |
| Luput Cristian | Director |
Nov 25 '25 |
Buy |
0.98 |
10,000 |
9,785 |
399,483 |
| Vitoc Vlad | Chief Executive Officer |
Nov 25 '25 |
Buy |
0.97 |
10,500 |
10,144 |
831,421 |
4.73%
0.92%
大文字化:
|
ボリューム (24 時間):